1. Home
  2. TLIH vs RNAZ Comparison

TLIH vs RNAZ Comparison

Compare TLIH & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLIH

Ten-League International Holdings Limited Ordinary Shares

HOLD

Current Price

$4.20

Market Cap

7.1M

Sector

N/A

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$7.81

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLIH
RNAZ
Founded
1998
2016
Country
Singapore
United States
Employees
62
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
8.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TLIH
RNAZ
Price
$4.20
$7.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.0M
5.2K
Earning Date
05-01-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.32
52 Week High
$7.00
$20.99

Technical Indicators

Market Signals
Indicator
TLIH
RNAZ
Relative Strength Index (RSI) 97.39 30.71
Support Level $0.38 $6.08
Resistance Level N/A $9.37
Average True Range (ATR) 0.39 0.45
MACD 0.45 -0.10
Stochastic Oscillator 87.35 0.00

Price Performance

Historical Comparison
TLIH
RNAZ

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: